MERRIMACK PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q2 2013 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Merrimack Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q2 2013 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Debt-to-equity for the quarter ending March 31, 2024 was 8.63 %, a 190% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 8.63 +5.66 +190% Mar 31, 2024
Q4 2023 2.39 -1.01 -29.7% Dec 31, 2023
Q3 2023 2.56 -1.09 -29.8% Sep 30, 2023
Q2 2023 2.71 -1.28 -32.1% Jun 30, 2023
Q1 2023 2.98 -1.48 -33.2% Mar 31, 2023
Q4 2022 3.4 -1.13 -25% Dec 31, 2022
Q3 2022 3.66 -1.07 -22.6% Sep 30, 2022
Q2 2022 3.98 -3.01 -43.1% Jun 30, 2022
Q1 2022 4.45 -4.67 -51.2% Mar 31, 2022
Q4 2021 4.53 -8.12 -64.2% Dec 31, 2021
Q3 2021 4.73 -10.6 -69.1% Sep 30, 2021
Q2 2021 6.99 -11.1 -61.3% Jun 30, 2021
Q1 2021 9.12 -7.42 -44.8% Mar 31, 2021
Q4 2020 12.7 -17.3 -57.8% Dec 31, 2020
Q3 2020 15.3 -23.3 -60.4% Sep 30, 2020
Q2 2020 18.1 -27.1 -60% Jun 30, 2020
Q1 2020 16.6 -29.8 -64.3% Mar 31, 2020
Q4 2019 30 -8.47 -22% Dec 31, 2019
Q3 2019 38.6 +7.75 +25.1% Sep 30, 2019
Q2 2019 45.1 +4.09 +9.96% Jun 30, 2019
Q1 2019 46.4 -13.2 -22.1% Mar 31, 2019
Q4 2018 38.4 -1.41K -97.4% Dec 31, 2018
Q3 2018 30.9 +314 Sep 30, 2018
Q2 2018 41.1 +216 Jun 30, 2018
Q1 2018 59.6 +204 Mar 31, 2018
Q4 2017 1.45K +1.61K Dec 31, 2017
Q3 2017 -283 -99.5 -54.1% Sep 30, 2017
Q2 2017 -175 +16.1 +8.42% Jun 30, 2017
Q1 2017 -144 +48.4 +25.1% Mar 31, 2017
Q4 2016 -161 +34.3 +17.6% Dec 31, 2016
Q3 2016 -184 +11.4 +5.84% Sep 30, 2016
Q2 2016 -191 +30.5 +13.8% Jun 30, 2016
Q1 2016 -193 +55.3 +22.3% Mar 31, 2016
Q4 2015 -195 +91 +31.8% Dec 31, 2015
Q3 2015 -195 +141 +41.8% Sep 30, 2015
Q2 2015 -222 +229 +50.8% Jun 30, 2015
Q1 2015 -248 +227 +47.8% Mar 31, 2015
Q4 2014 -286 +249 +46.5% Dec 31, 2014
Q3 2014 -336 +303 +47.4% Sep 30, 2014
Q2 2014 -451 +253 +36% Jun 30, 2014
Q1 2014 -475 Mar 31, 2014
Q4 2013 -535 Dec 31, 2013
Q3 2013 -639 Sep 30, 2013
Q2 2013 -704 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.